These findings establish a previously unrecognized mechanism whereby STEAP4+ myoCAF in the tumor microenvironment contribute to therapy resistance through TFE3‐regulated autophagy and HSP90/HIF1A‐mediated stemness. Here, HIF1A is linked to neoplasm.